EA200801854A1 - NEW COMPOSITIONS - Google Patents

NEW COMPOSITIONS

Info

Publication number
EA200801854A1
EA200801854A1 EA200801854A EA200801854A EA200801854A1 EA 200801854 A1 EA200801854 A1 EA 200801854A1 EA 200801854 A EA200801854 A EA 200801854A EA 200801854 A EA200801854 A EA 200801854A EA 200801854 A1 EA200801854 A1 EA 200801854A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
new compositions
fpf
variability
uniformity
Prior art date
Application number
EA200801854A
Other languages
Russian (ru)
Inventor
Джон Капекки
Джеймс Стифли
Тревор Рили
Original Assignee
Глаксо Груп Лимитед
3М Инновейтив Пропертиз Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801854(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глаксо Груп Лимитед, 3М Инновейтив Пропертиз Компани filed Critical Глаксо Груп Лимитед
Publication of EA200801854A1 publication Critical patent/EA200801854A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Abstract

Настоящее изобретение относится к новым фармацевтическим аэрозольным композициям, к способам их получения, к их применению в терапии, к дозирующим ингаляторам, содержащим указанные композиции, и к применению биосовместимых полимеров в уменьшении вариабельности однородности содержимого и/или в обеспечении улучшенной тонкодисперсной фракции (FPF) в указанных композициях.The present invention relates to new pharmaceutical aerosol compositions, to methods for their preparation, to their use in therapy, to metered dose inhalers containing said compositions, and to the use of biocompatible polymers in reducing the variability of uniformity of contents and / or in providing an improved fine fraction (FPF) in specified compositions.

EA200801854A 2006-03-22 2007-03-21 NEW COMPOSITIONS EA200801854A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78463406P 2006-03-22 2006-03-22
PCT/US2007/064462 WO2007109698A2 (en) 2006-03-22 2007-03-21 Novel formulations

Publications (1)

Publication Number Publication Date
EA200801854A1 true EA200801854A1 (en) 2009-04-28

Family

ID=38523271

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801854A EA200801854A1 (en) 2006-03-22 2007-03-21 NEW COMPOSITIONS

Country Status (18)

Country Link
EP (1) EP2012797A2 (en)
JP (1) JP2009530419A (en)
KR (1) KR20080110854A (en)
CN (1) CN101415428A (en)
AR (1) AR060039A1 (en)
AU (1) AU2007226899A1 (en)
BR (1) BRPI0708798A2 (en)
CA (1) CA2646236A1 (en)
CR (1) CR10261A (en)
EA (1) EA200801854A1 (en)
IL (1) IL193723A0 (en)
MA (1) MA30328B1 (en)
MX (1) MX2008011967A (en)
NO (1) NO20083760L (en)
PE (1) PE20080124A1 (en)
TW (1) TW200803870A (en)
WO (1) WO2007109698A2 (en)
ZA (1) ZA200807682B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2400950T3 (en) 2009-02-26 2019-07-29 Glaxo Group Ltd PHARMACEUTICAL FORMULA comprising 4 - {(1 R) -2 - [(6- {2 - [(2,6-DICHLORBENZYL) OXY] ETHOXY} HEXYL) AMINO] -1-HYDROXYETHYL} -2- (HYDROXYMETHYL) PHENOL
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2122261T3 (en) * 1993-03-17 1998-12-16 Minnesota Mining & Mfg AEROSOL FORMULATION CONTAINING A DISPERSION ADJUVANT DERIVED FROM AN ESTER, AMIDA OR MERCAPTOESTER.
AR032361A1 (en) * 2000-08-05 2003-11-05 Glaxo Group Ltd DERIVATIVES OF ANDROSTAN AND SALTS AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS, PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS, AND USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH COMPOUNDS
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative

Also Published As

Publication number Publication date
TW200803870A (en) 2008-01-16
CR10261A (en) 2008-11-26
NO20083760L (en) 2008-12-17
CN101415428A (en) 2009-04-22
BRPI0708798A2 (en) 2011-06-14
WO2007109698A3 (en) 2008-12-18
JP2009530419A (en) 2009-08-27
ZA200807682B (en) 2009-11-25
EP2012797A2 (en) 2009-01-14
KR20080110854A (en) 2008-12-19
CA2646236A1 (en) 2007-09-27
AR060039A1 (en) 2008-05-21
MA30328B1 (en) 2009-04-01
MX2008011967A (en) 2009-01-14
WO2007109698A2 (en) 2007-09-27
PE20080124A1 (en) 2008-04-21
IL193723A0 (en) 2009-08-03
AU2007226899A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
EA200802012A1 (en) PHARMACEUTICAL PREPARATIONS IN THE FORM OF SOLUTION FOR DOSING INHALERS UNDER PRESSURE
EA201491285A1 (en) IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID
MX2010005631A (en) Novel cyclic hydrocarbon compounds for the treatment of diseases.
MY168791A (en) Carbamate compounds and of making and using same
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
MX2007008379A (en) Methods and compositions for minimizing accrual of inhalable insulin in the lungs.
EA200800033A1 (en) COMPOSITION (OPTIONS), METHOD FOR ITS PREPARATION, TANK CONTAINING CONTAINING THE SPECIFIED COMPOSITION, AND METHOD FOR TREATING VIRAL DISEASES WITH ITS USE
MX2009003122A (en) Inhibitors of bruton's tyrosine kinase.
WO2007149406A3 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
EA201500432A1 (en) COMPOUNDS OF BONONATE AIR AND ITS PHARMACEUTICAL COMPOSITIONS
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
BR112015009559A2 (en) use of antisense compound in the preparation of cancer treatment medicament, antisense compound and pharmaceutical composition
LT2013015A (en) Pharmaceutical compositions
MX2009014235A (en) 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy.
BR112015018252A2 (en) stable fixed-dose aqueous pharmaceutical composition for nasal administration to a human, stable fixed-dose aqueous pharmaceutical composition for nasal administration for a human, stable suspension suitable for nasal administration to a human, method for treating rhinitis in a human human in need thereof, use of the pharmaceutical composition for nasal administration, method for releasing a pharmaceutical composition and kit
BR112014008609A2 (en) pharmaceutical composition, sealed container, metered dose inhaler, method for treating a patient suffering or likely to suffer from a respiratory disorder, and method for manufacturing a pharmaceutical composition
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
NZ606988A (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
EP2682101A3 (en) Inhalation Compositions Comprising Glucose Anhydrous
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
SE0402345D0 (en) A metered medication dose
CY1117596T1 (en) PHARMACEUTICAL AIRPORT COMPOSITIONS OF FORMOTEROL AND DIPROPIONAL VEHICLE
EP2682100A3 (en) Inhalation Compositions Comprising Muscarinic Receptor Antagonist
MX2015009891A (en) Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy.
EA200801854A1 (en) NEW COMPOSITIONS